[Form 4] Salesforce, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Salesforce, Inc. director John V. Roos reported a routine equity transaction involving restricted stock units (RSUs). On 11/22/2025, 274 RSUs converted into 274 shares of Salesforce common stock at an exercise price of $0, reflecting the typical nature of RSU settlements rather than a market purchase.
After this transaction, Roos beneficially owned 15,964 shares of Salesforce common stock in direct ownership. The 274 RSUs reported in the derivative table were fully settled, leaving no remaining units from that specific grant. These RSUs were scheduled to vest in four equal installments of 25% of the original grant on February 22, May 22, August 22, and November 22, 2025.
Positive
- None.
Negative
- None.
FAQ
What did Salesforce (CRM) director John V. Roos report in this Form 4?
John V. Roos reported that on 11/22/2025, 274 restricted stock units converted into 274 shares of Salesforce common stock at an exercise price of $0, a standard RSU settlement.
How many Salesforce (CRM) shares does John V. Roos own after this transaction?
Following the reported transaction, John V. Roos beneficially owned 15,964 shares of Salesforce common stock in direct ownership.
What happened to the restricted stock units reported by John V. Roos for Salesforce (CRM)?
The filing shows that 274 restricted stock units were exercised (coded "M") and converted into 274 shares of common stock, leaving 0 derivative securities from that specific RSU grant.
How were John V. Roos’s Salesforce (CRM) restricted stock units scheduled to vest?
The RSUs were scheduled to vest as to 25% of the original grant on each of February 22, 2025, May 22, 2025, August 22, 2025, and November 22, 2025.
Was there any cash consideration in John V. Roos’s Salesforce (CRM) RSU conversion?
No cash price was paid for the RSU conversion; the transaction shows an exercise price of $0, which is typical for restricted stock units converting into shares.